224 related articles for article (PubMed ID: 32298658)
41. Influenza Virus Hemagglutinin Glycoproteins with Different N-Glycan Patterns Activate Dendritic Cells In Vitro.
Liu WC; Lin YL; Spearman M; Cheng PY; Butler M; Wu SC
J Virol; 2016 Jul; 90(13):6085-6096. PubMed ID: 27099319
[TBL] [Abstract][Full Text] [Related]
42. Highly conserved sequences for human neutralization epitope on hemagglutinin of influenza A viruses H3N2, H1N1 and H5N1: Implication for human monoclonal antibody recognition.
Yamashita A; Kawashita N; Kubota-Koketsu R; Inoue Y; Watanabe Y; Ibrahim MS; Ideno S; Yunoki M; Okuno Y; Takagi T; Yasunaga T; Ikuta K
Biochem Biophys Res Commun; 2010 Mar; 393(4):614-8. PubMed ID: 20152806
[TBL] [Abstract][Full Text] [Related]
43. Shotgun glycomics of pig lung identifies natural endogenous receptors for influenza viruses.
Byrd-Leotis L; Liu R; Bradley KC; Lasanajak Y; Cummings SF; Song X; Heimburg-Molinaro J; Galloway SE; Culhane MR; Smith DF; Steinhauer DA; Cummings RD
Proc Natl Acad Sci U S A; 2014 Jun; 111(22):E2241-50. PubMed ID: 24843157
[TBL] [Abstract][Full Text] [Related]
44. Conserved synthetic peptides from the hemagglutinin of influenza viruses induce broad humoral and T-cell responses in a pig model.
Vergara-Alert J; Argilaguet JM; Busquets N; Ballester M; Martín-Valls GE; Rivas R; López-Soria S; Solanes D; Majó N; Segalés J; Veljkovic V; Rodríguez F; Darji A
PLoS One; 2012; 7(7):e40524. PubMed ID: 22815759
[TBL] [Abstract][Full Text] [Related]
45. Human Influenza A Virus Hemagglutinin Glycan Evolution Follows a Temporal Pattern to a Glycan Limit.
Altman MO; Angel M; Košík I; Trovão NS; Zost SJ; Gibbs JS; Casalino L; Amaro RE; Hensley SE; Nelson MI; Yewdell JW
mBio; 2019 Apr; 10(2):. PubMed ID: 30940704
[TBL] [Abstract][Full Text] [Related]
46. Glycan shielding of the influenza virus hemagglutinin contributes to immunopathology in mice.
Wanzeck K; Boyd KL; McCullers JA
Am J Respir Crit Care Med; 2011 Mar; 183(6):767-73. PubMed ID: 20935106
[TBL] [Abstract][Full Text] [Related]
47. Multi-task learning sparse group lasso: a method for quantifying antigenicity of influenza A(H1N1) virus using mutations and variations in glycosylation of Hemagglutinin.
Li L; Chang D; Han L; Zhang X; Zaia J; Wan XF
BMC Bioinformatics; 2020 May; 21(1):182. PubMed ID: 32393178
[TBL] [Abstract][Full Text] [Related]
48. Mechanism of glycan receptor recognition and specificity switch for avian, swine, and human adapted influenza virus hemagglutinins: a molecular dynamics perspective.
Newhouse EI; Xu D; Markwick PR; Amaro RE; Pao HC; Wu KJ; Alam M; McCammon JA; Li WW
J Am Chem Soc; 2009 Dec; 131(47):17430-42. PubMed ID: 19891427
[TBL] [Abstract][Full Text] [Related]
49. Comprehensive N-glycosylation analysis of the influenza A virus proteins HA and NA from adherent and suspension MDCK cells.
Pralow A; Hoffmann M; Nguyen-Khuong T; Pioch M; Hennig R; Genzel Y; Rapp E; Reichl U
FEBS J; 2021 Aug; 288(16):4869-4891. PubMed ID: 33629527
[TBL] [Abstract][Full Text] [Related]
50. Conserved neutralizing epitope at globular head of hemagglutinin in H3N2 influenza viruses.
Iba Y; Fujii Y; Ohshima N; Sumida T; Kubota-Koketsu R; Ikeda M; Wakiyama M; Shirouzu M; Okada J; Okuno Y; Kurosawa Y; Yokoyama S
J Virol; 2014 Jul; 88(13):7130-44. PubMed ID: 24719430
[TBL] [Abstract][Full Text] [Related]
51. A cross-neutralizing antibody between HIV-1 and influenza virus.
Lee CD; Watanabe Y; Wu NC; Han J; Kumar S; Pholcharee T; Seabright GE; Allen JD; Lin CW; Yang JR; Liu MT; Wu CY; Ward AB; Crispin M; Wilson IA
PLoS Pathog; 2021 Mar; 17(3):e1009407. PubMed ID: 33750987
[TBL] [Abstract][Full Text] [Related]
52. Genetically destined potentials for N-linked glycosylation of influenza virus hemagglutinin.
Igarashi M; Ito K; Kida H; Takada A
Virology; 2008 Jul; 376(2):323-9. PubMed ID: 18456302
[TBL] [Abstract][Full Text] [Related]
53. Molecular evolution of human influenza A viruses in a local area during eight influenza epidemics from 2000 to 2007.
Zaraket H; Saito R; Sato I; Suzuki Y; Li D; Dapat C; Caperig-Dapat I; Oguma T; Sasaki A; Suzuki H
Arch Virol; 2009; 154(2):285-95. PubMed ID: 19153639
[TBL] [Abstract][Full Text] [Related]
54. Topological N-glycosylation and site-specific N-glycan sulfation of influenza proteins in the highly expressed H1N1 candidate vaccines.
She YM; Farnsworth A; Li X; Cyr TD
Sci Rep; 2017 Aug; 7(1):10232. PubMed ID: 28860626
[TBL] [Abstract][Full Text] [Related]
55. The number and position of N-linked glycosylation sites in the hemagglutinin determine differential recognition of seasonal and 2009 pandemic H1N1 influenza virus by porcine surfactant protein D.
Hillaire ML; van Eijk M; Nieuwkoop NJ; Vogelzang-van Trierum SE; Fouchier RA; Osterhaus AD; Haagsman HP; Rimmelzwaan GF
Virus Res; 2012 Oct; 169(1):301-5. PubMed ID: 22921759
[TBL] [Abstract][Full Text] [Related]
56. Glycosylation changes in the globular head of H3N2 influenza hemagglutinin modulate receptor binding without affecting virus virulence.
Alymova IV; York IA; Air GM; Cipollo JF; Gulati S; Baranovich T; Kumar A; Zeng H; Gansebom S; McCullers JA
Sci Rep; 2016 Oct; 6():36216. PubMed ID: 27796371
[TBL] [Abstract][Full Text] [Related]
57. The use of plant lectins to regulate H1N1 influenza A virus receptor binding activity.
Lee N; Khalenkov AM; Lugovtsev VY; Ireland DD; Samsonova AP; Bovin NV; Donnelly RP; Ilyushina NA
PLoS One; 2018; 13(4):e0195525. PubMed ID: 29630683
[TBL] [Abstract][Full Text] [Related]
58. Analysis of the Contrasting Pathogenicities Induced by the D222G Mutation in 1918 and 2009 Pandemic Influenza A Viruses.
Shang C; Whittleston CS; Sutherland-Cash KH; Wales DJ
J Chem Theory Comput; 2015 May; 11(5):2307-14. PubMed ID: 26321885
[TBL] [Abstract][Full Text] [Related]
59. Influenza immunization elicits antibodies specific for an egg-adapted vaccine strain.
Raymond DD; Stewart SM; Lee J; Ferdman J; Bajic G; Do KT; Ernandes MJ; Suphaphiphat P; Settembre EC; Dormitzer PR; Del Giudice G; Finco O; Kang TH; Ippolito GC; Georgiou G; Kepler TB; Haynes BF; Moody MA; Liao HX; Schmidt AG; Harrison SC
Nat Med; 2016 Dec; 22(12):1465-1469. PubMed ID: 27820604
[TBL] [Abstract][Full Text] [Related]
60. Phenotypic Effects of Substitutions within the Receptor Binding Site of Highly Pathogenic Avian Influenza H5N1 Virus Observed during Human Infection.
Eggink D; Spronken M; van der Woude R; Buzink J; Broszeit F; McBride R; Pawestri HA; Setiawaty V; Paulson JC; Boons GJ; Fouchier RAM; Russell CA; de Jong MD; de Vries RP
J Virol; 2020 Jun; 94(13):. PubMed ID: 32321815
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
